78 related articles for article (PubMed ID: 3698048)
1. Mitoguazone in advanced squamous cell carcinoma of head and neck origin: a phase II trial of the Southeastern Cancer Study Group.
Luedke DW; Maddox W; Birch R; Velez-Garcia E; Schleuter J
Cancer Treat Rep; 1986 Apr; 70(4):529-30. PubMed ID: 3698048
[No Abstract] [Full Text] [Related]
2. Phase II trial of mitoguazone in patients with advanced squamous cell carcinoma of the head and neck.
Perry DJ; Crain SM; Weltz MD; Wilson JP; Davis RK; Woolley PV; Forastiere AA; Taylor HG; Weiss RB
Cancer Treat Rep; 1983 Jan; 67(1):91-2. PubMed ID: 6616496
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of mitoguazone in patients with advanced head and neck cancer.
Thongprasert S; Bosl GJ; Geller NL; Wittes RE
Cancer Treat Rep; 1984 Oct; 68(10):1301-2. PubMed ID: 6525604
[No Abstract] [Full Text] [Related]
4. Phase II evaluation of mitoguazone in cancers of the esophagus, stomach, and pancreas: a Southeastern Cancer Study Group Trial.
Ravry MJ; Omura GA; Hill GJ; Bartolucci AA; Velez-Garcia E
Cancer Treat Rep; 1986 Apr; 70(4):533-4. PubMed ID: 3698050
[No Abstract] [Full Text] [Related]
5. [Phase II trial of mitoguazone in patients with recurrent extensive cervicofacial tumors].
Coninx P; Nasca S; Jezekova D; Roelandt H; Morel M; Legros M; Cattan A
Bull Cancer; 1985; 72(2):153-4. PubMed ID: 4005436
[No Abstract] [Full Text] [Related]
6. Phase II evaluation of mitolactol in squamous cell carcinoma of the head and neck: a Southeastern Cancer Study Group Trial.
McHale MS; Velez-Garcia E; Nelson O; Williams SD; Maddox W; Birch R
Cancer Treat Rep; 1986 Jul; 70(7):925-6. PubMed ID: 3521849
[No Abstract] [Full Text] [Related]
7. Phase II trial of vindesine in advanced squamous cell cancer of the head and neck.
Vogl SE; Camacho FJ; Kaplan BH; O'Donnell MR
Cancer Treat Rep; 1984 Mar; 68(3):559-60. PubMed ID: 6704987
[No Abstract] [Full Text] [Related]
8. Phase II trial of high-dose cytarabine and cisplatin in locoregional previously untreated squamous carcinoma of the head and neck: a Piedmont Oncology Association Study.
Craig JB; Powell BL; Jackson DV; Atkins JN; Smith LR; White DR; Richards F; Capizzi RL
Cancer Treat Rep; 1987 Feb; 71(2):151-3. PubMed ID: 3802112
[No Abstract] [Full Text] [Related]
9. Phase II trial of 4'-epi-doxorubicin in advanced carcinoma of head and neck origin.
Magee MJ; Howard J; Bosl GJ; Wittes RE
Cancer Treat Rep; 1985 Jan; 69(1):125-6. PubMed ID: 3855384
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of thioproline in advanced epidermoid head and neck tumors.
Boccardo F; Barbieri A; Canobbio L; Guarneri D; Merlano M; Rosso R
Cancer Treat Rep; 1982 Mar; 66(3):585-6. PubMed ID: 7060048
[No Abstract] [Full Text] [Related]
11. Phase II trial of ICRF-187 in squamous cell carcinoma of the head and neck.
Wheeler RH; Bricker LJ; Natale RB; Baker SR
Cancer Treat Rep; 1984 Feb; 68(2):427-8. PubMed ID: 6421483
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of pyrazofurin in advanced head and neck cancer.
Cheng E; Currie V; Wittes RE
Cancer Treat Rep; 1979; 63(11-12):2047-8. PubMed ID: 526937
[No Abstract] [Full Text] [Related]
13. Phase II trial of bisantrene in advanced epidermoid carcinoma of the head and neck.
Forastiere AA; Crain SM; Garbino C; Tipping SJ; Perry DJ; Kasdorf H; Van Echo DA
Cancer Treat Rep; 1984 Apr; 68(4):687-8. PubMed ID: 6713424
[No Abstract] [Full Text] [Related]
14. Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390).
Forastiere AA; Shank D; Neuberg D; Taylor SG; DeConti RC; Adams G
Cancer; 1998 Jun; 82(11):2270-4. PubMed ID: 9610709
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of methyl-GAG in the treatment of esophageal carcinoma.
Kelsen D; Chapman R; Bains M; Heelan R; Dukeman M; Golbey R
Cancer Treat Rep; 1982 Jun; 66(6):1427-9. PubMed ID: 7083245
[TBL] [Abstract][Full Text] [Related]
16. Inefficacy of methylglyoxal bis(guanylhydrazone) (MGBG) in patients with recurrent head and neck squamous cell carcinoma.
Arteaga CL; Clark GM
Invest New Drugs; 1989 Jul; 7(2-3):281-3. PubMed ID: 2793385
[No Abstract] [Full Text] [Related]
17. Aclacinomycin. Phase II evaluation in advanced squamous carcinoma of the head and neck.
Kish JA; Al-Sarraf M
Am J Clin Oncol; 1984 Oct; 7(5):535-7. PubMed ID: 6507374
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of etoposide in previously untreated squamous cell carcinoma of the head and neck.
Cobleigh MA; Hill JH; Lad TE; Shevrin DE; Applebaum EL
Cancer Treat Rep; 1987 Mar; 71(3):321-2. PubMed ID: 3815398
[No Abstract] [Full Text] [Related]
19. Phase II evaluation of maytansine in patients with advanced head and neck cancer.
Creagan ET; Fleming TR; Edmonson JH; Ingle JN
Cancer Treat Rep; 1979; 63(11-12):2061-2. PubMed ID: 526939
[No Abstract] [Full Text] [Related]
20. Phase II evaluation of mitoguazone in metastatic hormone-resistant prostate cancer: a Southeastern Cancer Study Group trial.
Moore MR; Graham SD; Birch R; Irwin L
Cancer Treat Rep; 1987 Jan; 71(1):89-90. PubMed ID: 3791273
[No Abstract] [Full Text] [Related]
[Next] [New Search]
